|
First case of mirtazepine-induced Stevens-Johnson syndrome from India
Amit Bhasin, Anil Gurtoo, Latika Gupta, Gunjan Aggarwal
Department of Medicine, Lady Hardinge Medical College, New Delhi, India
Correspondence Address:
Amit Bhasin
Department of Medicine, Lady Hardinge Medical College, New Delhi
India
A 28-year-old woman, a known case of systemic lupus erythematosus (SLE), was admitted with mucocutaneous ulceroerosive lesions with blisters and thrombocytopenia after taking antidepressant mirtazepine. Exacerbation of SLE and drug-induced eruption was diagnosed. Clinical and laboratory markers were suggestive of Stevens-Johnson syndrome. This is a rare adverse effect of the newer generation antidepressant mirtazepine.
How to cite this article:
Bhasin A, Gurtoo A, Gupta L, Aggarwal G. First case of mirtazepine-induced Stevens-Johnson syndrome from India.Indian J Pharmacol 2012;44:656-658
|
How to cite this URL:
Bhasin A, Gurtoo A, Gupta L, Aggarwal G. First case of mirtazepine-induced Stevens-Johnson syndrome from India. Indian J Pharmacol [serial online] 2012 [cited 2023 Dec 9 ];44:656-658
Available from: https://www.ijp-online.com/article.asp?issn=0253-7613;year=2012;volume=44;issue=5;spage=656;epage=658;aulast=Bhasin;type=0 |
|
